Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Stardust Dairy, LLC
WARNING LETTER
•Stardust Dairy, LLC•November 20, 2009

FDA WARNING_LETTER - Stardust Dairy, LLC - November 20, 2009

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA conducted an inspection of Stardust Dairy, LLC, owned by Franciscus X.J. Van Genugten, from October 16 to November 20, 2009, at their South Solon, OH facility. The inspection revealed significant violations of the Federal Food, Drug, and Cosmetic Act. The primary violation involved offering an adulterated animal for slaughter as food. Specifically, a cow with ear tag (b)(4), slaughtered on April 21, 2009, was found to have Flunixin residue in its liver at 0.1689 ppm, exceeding the established tolerance of 0.125 ppm (21 CFR 556.286), rendering the food adulterated under 21 U.S.C. 342(a)(2)(C)(ii). Furthermore, the investigation identified that Stardust Dairy holds animals under inadequate conditions, increasing the risk of medicated animals with potentially harmful drug residues entering the food supply. This constitutes adulteration under 21 U.S.C. 342(a)(4). Deficiencies included a lack of an adequate inventory system for drug quantities and incomplete drug treatment records for medicated animals. The FDA requires prompt corrective action to address these violations and establish procedures to prevent recurrence. Stardust Dairy must submit a written response within fifteen working days, detailing all corrective steps taken or planned, including documentation. Failure to comply may lead to regulatory actions such as seizure or injunction.

Company
Stardust Dairy, LLC
Inspection Date
November 20, 2009
Product Type
Drugs
Office
Cincinnati District Office
Person
  • Teresa C. Thompson
Open in Dashboard

ID · 6beb60c9-01ce-42b0-92d9-bf6198622349

Violation Codes4
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 556.286

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.